Legal status · United States
Is Bromantane legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Bromantane is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Bromantane in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | No FDA approval and no FDA label. Prohibited in-competition for athletes: bromantan appears on the 2026 WADA Prohibited List under S6.A, non-specified stimulants. |
| FDA approval status | Not approved by the FDA for any indication, and no FDA label exists. It is registered and marketed in Russia for asthenia under the name Ladasten. Sold in the United States and elsewhere as a research chemical or an unapproved nootropic supplement. |
| Human studies cited | 3 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Bromantane profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Bromantane is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Bromantane is
The only compound in this batch with randomised placebo-controlled human trials, and every one of them measured fatigue and anxiety rating scales in neurasthenia, not cognition. The entire clinical literature is Russian language, small, and traces to one Moscow research group. It is on the 2026 WADA Prohibited List as a non-specified stimulant, prohibited in-competition.
Bromantane is the compound in this batch that people actually search for and actually buy, and it is also the one where the English-language internet is least useful, because its clinical record is indexed under two names and published almost entirely in Russian. Searching PubMed for bromantane alone returns a partial picture.
Mechanism: Demonstrated in rats, proposed in humans. It is an adamantane derivative, not a peptide, and it is classed in Russian pharmacology as an actoprotector rather than a stimulant.
Regulatory history: Not approved by the FDA for any indication, and no FDA label exists. It is registered and marketed in Russia for asthenia under the name Ladasten. Sold in the United States and elsewhere as a research chemical or an unapproved nootropic supplement.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Bromantane at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Bromantane in other countries
Frequently asked questions
Is Bromantane legal in the United States?
No. Bromantane is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile. Note: No FDA approval and no FDA label. Prohibited in-competition for athletes: bromantan appears on the 2026 WADA Prohibited List under S6.A, non-specified stimulants.
Can I buy Bromantane in the United States?
No approved product exists to buy. In the United States Bromantane is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No FDA approval and no FDA label. Prohibited in-competition for athletes: bromantan appears on the 2026 WADA Prohibited List under S6.A, non-specified stimulants.
Is Bromantane FDA approved?
No. FDA status: Not approved by the FDA for any indication, and no FDA label exists. It is registered and marketed in Russia for asthenia under the name Ladasten. Sold in the United States and elsewhere as a research chemical or an unapproved nootropic supplement.. Current US classification: "Not approved; research use only". On the evidence, 3 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Bromantane live on its compound profile.
Bromantane profileThis page is general information about the regulatory status of Bromantane in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.